Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
     free
  
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
     free
      free 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll Aminoglycoside modifying enzymes Ramirez MS; Tolmasky MEDrug Resist Updat  2010[Dec]; 13 (6): 151-71Aminoglycosides have been an essential component of the armamentarium in the  treatment of life-threatening infections. Unfortunately, their efficacy has been  reduced by the surge and dissemination of resistance. In some cases the levels of  resistance reached the point that rendered them virtually useless. Among many  known mechanisms of resistance to aminoglycosides, enzymatic modification is the  most prevalent in the clinical setting. Aminoglycoside modifying enzymes catalyze  the modification at different -OH or -NH(2) groups of the 2-deoxystreptamine  nucleus or the sugar moieties and can be nucleotidyltransferases,  phosphotransferases, or acetyltransferases. The number of aminoglycoside  modifying enzymes identified to date as well as the genetic environments where  the coding genes are located is impressive and there is virtually no bacteria  that is unable to support enzymatic resistance to aminoglycosides. Aside from the  development of new aminoglycosides refractory to as many as possible modifying  enzymes there are currently two main strategies being pursued to overcome the  action of aminoglycoside modifying enzymes. Their successful development would  extend the useful life of existing antibiotics that have proven effective in the  treatment of infections. These strategies consist of the development of  inhibitors of the enzymatic action or of the expression of the modifying enzymes.|Aminoglycosides/*metabolism/pharmacology/therapeutic use[MESH]|Animals[MESH]|Bacteria/*enzymology[MESH]|Drug Resistance, Bacterial/physiology[MESH]|Humans[MESH]|Transferases/genetics/*metabolism[MESH] |